Leap therapeutics announces publication of dkn-01 mechanism of action data in molecular cancer research

Cambridge, mass., dec. 22, 2020 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the publication in molecular cancer research of preclinical results from studies of human and...
LPTX Ratings Summary
LPTX Quant Ranking